Contact us for free information or to start a free case review.
The FDA says it is working with the National Institutes of Health to review available scientific information on naproxen, sold under the brand name Aleve by Bayer, after the decision to halt a clinical trial studying the effect of naproxen on patients at risk of developing Alzheimer’s disease was made. The decision came when preliminary information from the study showed some evidence of increased risk of cardiovascular events when comparing patients taking naproxen to a placebo.
Naproxen users were 50 percent more likely to have heart attacks or strokes. Part of a class of drugs known as nonsteroidal anti-inflammatory drugs, or NSAIDs, naproxen is used for a wide variety of ailments. The study’s principal investigator, Dr. John Breitner, says that he has more questions than answers because “we’ve never had the opportunity to study that,” and now researchers are questioning the safety of all NSAID drugs, not just naproxen.
The FDA is advising patients currently taking naproxen to carefully follow instructions on the label and avoid taking doses higher than recommended. In addition, the agency warns naproxen should not be taken for longer than ten days unless a physician directs otherwise.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.